GlassScriptPhysician profile
Robert T Martin
NPI 1801886585
$6,123.18
in general payments reported to CMS, 2019-2025
45 companies · $1,037 in 2025
The $1,037 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,309 · 2020: $574 · 2021: $686 · 2022: $871 · 2023: $856 · 2024: $789 · 2025: $1,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,682.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $936.71 | 2019-2025 | Accolade Sr, Jetstream Sc, Avvigo Guidance System |
| Abiomed | $835.09 | 2019-2025 | Impella |
| Shockwave Medical, INC | $395.89 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $380.46 | 2021-2025 | Cobalt Dr Mri Surescan, Onyx Frontier, Azure Xt Dr Mri Surescan |
| Pfizer INC. | $287.36 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $263.87 | 2019-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $239.89 | 2019-2025 | Eliquis, Camzyos |
| Kestra Medical Technology Services, INC. | $205.26 | 2025 | Assure Wcd |
| Amgen INC. | $183.55 | 2019-2024 | Repatha |
| Esperion Therapeutics, INC. | $153.98 | 2022-2024 | Nexletol |
| Akcea Therapeutics, INC. | $145.32 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $134.49 | 2021-2024 | |
| Itamar Medical INC | $130.39 | 2022-2025 | Watchpatone |
| Alnylam Pharmaceuticals INC. | $125.87 | 2022-2023 | |
| Amarin Pharma, INC. | $125.00 | 2019 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.